| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b5a91fcfdbeaa99fa93f26da82b196a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 |
| filingDate |
2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc72bfa77ea74abc46332c39525d666f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec52463a5899dc7ba1a53d4b1aa5ff6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fedc690efc0b89d671ad31184ceb7cd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85232e22cb79f86ccc50ec7b12f84e5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_372a8c8c3b6671ed4591ad03bed0fdd9 |
| publicationDate |
2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170071393-A |
| titleOfInvention |
Composition for diagnosis of radioresistance and use thereof |
| abstract |
The present invention relates to a biomarker composition for the diagnosis of radiation resistance of breast cancer cells, which comprises gene mRNA consisting of STAT3 and survivin or a protein group thereof as an active ingredient, and its use, and more particularly to a biomarker composition for HR- / HER2 + Have been shown to be due to increased activity or expression of STAT3 and survivin, the STAT3 and survivin genes or their proteins can be provided as biomarkers for the prediction of radiation resistance in HR- / HER2 breast cancer patients , And the effect of radiation therapy on breast cancer patients can be improved by controlling their expression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200066921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200083804-A |
| priorityDate |
2015-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |